BERARDO, CLARISSA ANGELA IRIS
 Distribuzione geografica
Continente #
NA - Nord America 1.874
AS - Asia 1.153
EU - Europa 1.085
SA - Sud America 194
AF - Africa 29
OC - Oceania 5
Totale 4.340
Nazione #
US - Stati Uniti d'America 1.824
CN - Cina 530
IE - Irlanda 394
SG - Singapore 253
RU - Federazione Russa 208
HK - Hong Kong 176
BR - Brasile 155
DE - Germania 119
FI - Finlandia 87
VN - Vietnam 82
IT - Italia 80
GB - Regno Unito 36
CA - Canada 35
BE - Belgio 27
FR - Francia 26
CZ - Repubblica Ceca 25
JP - Giappone 24
SE - Svezia 24
IN - India 21
BD - Bangladesh 17
AR - Argentina 16
MX - Messico 13
PL - Polonia 12
ZA - Sudafrica 11
UA - Ucraina 10
EC - Ecuador 8
ID - Indonesia 7
EG - Egitto 6
AE - Emirati Arabi Uniti 5
AT - Austria 5
CO - Colombia 5
LT - Lituania 5
NL - Olanda 5
TR - Turchia 5
ES - Italia 4
IQ - Iraq 4
KR - Corea 4
PK - Pakistan 4
PY - Paraguay 4
DZ - Algeria 3
IL - Israele 3
JO - Giordania 3
LV - Lettonia 3
MA - Marocco 3
NZ - Nuova Zelanda 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
CL - Cile 2
IR - Iran 2
PE - Perù 2
RO - Romania 2
UZ - Uzbekistan 2
AL - Albania 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
CH - Svizzera 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GR - Grecia 1
HR - Croazia 1
IM - Isola di Man 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
MM - Myanmar 1
MU - Mauritius 1
NC - Nuova Caledonia 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
PS - Palestinian Territory 1
QA - Qatar 1
SA - Arabia Saudita 1
TH - Thailandia 1
TM - Turkmenistan 1
VE - Venezuela 1
Totale 4.340
Città #
Chandler 427
Dublin 392
Beijing 181
Hong Kong 176
Ashburn 140
Dallas 138
Singapore 106
Boardman 72
Los Angeles 64
Helsinki 63
Moscow 60
Princeton 60
Lawrence 58
Medford 56
Munich 56
Shanghai 56
Nanjing 42
New York 37
Pavia 35
Wilmington 35
Ann Arbor 27
Brussels 27
Buffalo 27
Ho Chi Minh City 27
Jacksonville 27
Redondo Beach 27
Tokyo 24
Brno 21
Hanoi 19
Hebei 17
Nanchang 17
São Paulo 17
Turku 16
Toronto 15
Changsha 13
Hangzhou 13
Atlanta 12
Tianjin 12
Warsaw 12
Montreal 11
San Francisco 11
Monza 10
Shenyang 10
Columbus 9
Houston 9
Johannesburg 9
Seattle 9
Düsseldorf 8
Jiaxing 8
Mexico City 8
Poplar 8
Santa Clara 8
The Dalles 8
Chennai 7
Denver 7
Des Moines 7
Fairfield 7
Lauterbourg 7
London 7
Orem 7
Frankfurt am Main 6
Belo Horizonte 5
Brooklyn 5
Chicago 5
Dhaka 5
Raleigh 5
Redwood City 5
Berlin 4
Brescia 4
Cagliari 4
Charlotte 4
Da Nang 4
Dearborn 4
Falls Church 4
Guangzhou 4
Laurel 4
Nuremberg 4
Quito 4
Rio de Janeiro 4
Seoul 4
Washington 4
Alexandria 3
Americana 3
Amman 3
Amsterdam 3
Asunción 3
Auckland 3
Baghdad 3
Brdo 3
Campinas 3
Guayaquil 3
Haiphong 3
Hefei 3
Jakarta 3
Milan 3
New Delhi 3
Paris 3
Portsmouth 3
Ribeirão Preto 3
Riga 3
Totale 2.948
Nome #
Changes in ADMA/DDAH pathway after hepatic ischemia/reperfusion injury in rats: the role of bile. 153
Animal Models of Steatosis (NAFLD) and Steatohepatitis (NASH) Exhibit Hepatic Lobe-Specific Gelatinases Activity and Oxidative Stress 122
Associations between serum trace elements and inflammation in two animal models of nonalcoholic fatty liver disease 107
Changes in biliary levels of arginine and its methylated derivatives after hepatic ischaemia/reperfusion 105
Autofluorescence discrimination of metabolic fingerprint in nutritional and genetic fatty liver models 105
Liver plays a central role in asymmetric dimethylarginine-mediated organ injury 102
Fluorescing fatty acids in rat fatty liver models 98
Serum and hepatic autofluorescence as a real-time diagnostic tool for early cholestasis assessment 95
Fatty liver oxidative events monitored by autofluorescence optical diagnosis: Comparison between subnormothermic machine perfusion and conventional cold storage preservation 95
Comparison between Lipofectamine RNAiMAX and GenMute transfection agents in two cellular models of human hepatoma 92
Analysis of Massaciuccoli Peat after Maturation in Sodium Chloride Water of Undulna Thermae 91
Increase in transporter MATE-1 expression induced by obeticholic acid correlates with higher biliary excretion of asymmetric dimethylarginine during hepatic ischemia/reperfusion injury 90
Alterations in stearoyl-CoA-desaturase index and metalloproteinase activity in nutritional versus genetic rat models of NAFLD 88
Allosteric modulation of mGlu5 receptors by MPEP protects against hepatic cold ischemia and reperfusion injury 86
Liver graft susceptibility during static cold storage and dynamic machine perfusion: DCD versus fatty livers 84
Detailed Molecular Mechanisms Involved in Drug-Induced Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: An Update 83
Fatty acid desaturase involvement in non-alcoholic fatty liver disease rat models: Oxidative stress versus metalloproteinases 80
Nonalcoholic fatty liver disease and non-alcoholic steatohepatitis: Current issues and future perspectives in preclinical and clinical research 80
Long-term cold storage preservation does not affect fatty livers from rats fed with a methionine and choline deficient diet 80
Oxygen tension-independent protection against hypoxic cell killing in rat liver by low sodium 78
Localization and role of metabotropic glutamate receptors subtype 5 in the gastrointestinal tract 77
Selective blockade of the metabotropic glutamate receptor mGluR5 protects mouse livers in in vitro and ex vivo models of ischemia reperfusion injury 77
MPEP, a metabotropic Glutamate Receptor 5 (mGluR5) negative allosteric modulator, protects from hepatic ischemic injury both in vitro and ex vivo. 76
Isolation of rat hepatocytes for pharmacological studies on metabotropic glutamate receptor (mGluR) subtype 5: a comparison between collagenase I versus collagenase IV. 76
Fatty liver susceptibility to preservation injury using static cold storage versus dynamic machine perfusion 74
MCD diet-induced steatohepatitis is associated with alterations in asymmetric dimethylarginine (ADMA) and its transporters 72
Benefits of Physical Exercise as Approach to Prevention and Reversion of Non-Alcoholic Fatty Liver Disease in Children and Adolescents with Obesity 70
The farnesoid X receptor agonist obeticholic acid upregulates biliary excretion of asymmetric dimethylarginine via MATE-1 during hepatic ischemia/reperfusion injury 70
MicroCT evaluation of low-density segmented volume in II, IV and VII-week MCD rats 70
Hepatic ischemia induces a time-dependent increase in SERPINB3 gene expression 68
Obeticholic acid restores hepatic RECK content in a diet-induced ob/ob mouse model of NASH 68
Fluorescence excitation properties of bilirubin in solution and in serum 68
Spectrofluorometric analysis of autofluorescing components of crude serum from a rat liver model of ischemia and reperfusion 67
Obeticholic Acid Reduces Kidney Matrix Metalloproteinase Activation Following Partial Hepatic Ischemia/Reperfusion Injury in Rats 66
The FXR agonist obeticholic acid decreases matrix metalloproteinase activity via RECK and TIMP modulation in hepatic ischemia/reperfusion injury 66
The selective blockade of metabotropic glutamate receptor-5 attenuates fat accumulation in an in vitro model of benign steatosis 63
Cold ischemic injury is reduced by the mGluR5 negative allosteric modulator MPEP in rat livers from cardiac death donors 63
SAT-389-Obeticholic acid reduces matrix metalloproteinases activity via iNOS modulation in hepatic ischemia/reperfusion injury 60
Metabotropic glutamate receptor blockade reduces preservation damage in livers from donors after cardiac death 59
Obeticholic acid reduces biliary and hepatic matrix metalloproteinases activity in rat hepatic ischemia/reperfusion injury 58
Hepatic ischemia induces a time-dependent increase in SerpinB3 gene expression 58
P0006 : Hepatic ischemia/reperfusion induces changes in tissue and biliary levels of arginine and its methylated derivatives 58
OCA administration reduces lung matrix metalloproteinase activation following hepatic ischemia/reperfusion injury in rats 58
Selective Blockade of Metabotropic Glutamate Receptor by MPEP Protects against Hepatic Cold Ischemia and Reperfusion Injury 58
Hepatic ischemic injury decreases using negative allosteric modulators of metabotropic glutamate receptor subtype 5 58
INOS-mediated decrease of matrix metalloproteinase activity by obeticholic acid in hepatic ischemia/reperfusion 57
Negative allosteric modulators of metabotropic glutamate receptor subtype 5 protect against hepatic ischemia/reperfusion injury 57
Changes in glutathione content in liver diseases: An update 55
NAD(P)H and Flavin Autofluorescence Correlation with ATP in Rat Livers with Different Metabolic Steady-State Conditions 54
MPEP administration reduces steatosis and inflammation in ob/ob mice 54
RECK- and TIMP-mediated downregulation of matrix metalloproteinase activity by obeticholic acid in hepatic ischemia/reperfusion 53
Machine perfusion at 20°C prevents ischemic injury and reduces hypoxia-inducible factor-1α expression during rat liver preservation 52
Lobe-specific oxidative stress and matrix metalloproteinase activation in two animal models of non-alcoholic fatty liver disease (NAFLD) 52
MPEP Attenuates Intrahepatic Fat Accumulation in Obese Mice 51
Further increase in biliary excretion of asymmetric dimethylarginine during hepatic ischemia/reperfusion injury by obeticholic acid, a farnesoid-X-receptor agonist 51
The Farnesoid-X-Receptor Agonist Obeticholic Acid Further Increases Biliary Excretion of Asymmetric Dimethylarginine during Hepatic Ischemia/Reperfusion Injury 48
Oxidative stress, mitochondria damage and matrix metalloprotease activation in the pathogenesis of NAFLD 48
The Effect of Healthy Lifestyle Strategies on the Management of Insulin Resistance in Children and Adolescents with Obesity: A Narrative Review 47
Transient Expression of Reck Under Hepatic Ischemia/Reperfusion Conditions Is Associated with Mapk Signaling Pathways 43
Upregulation of MATE-1 transporter by obeticholic acid correlates with increased biliary excretion of asymmetric dimethylarginine during hepatic ischemia/reperfusion injury 43
Use of Physical Activity and Exercise to Reduce Inflammation in Children and Adolescents with Obesity 37
Innovative targets involved in the progression of NASH: Asymmetric-dymethylarginine (ADMA) and its cationic transporters 31
Metalloproteinases activation involvement in the progression of liver injury from NAFLD to NASH 29
Transient Expression of Reck Under Hepatic Ischemia/Reperfusion Conditions Is Associated with Mapk Signaling Pathways 24
Totale 4.458
Categoria #
all - tutte 21.709
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.709


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202172 0 0 0 0 0 15 17 17 11 6 5 1
2021/2022299 1 3 4 2 6 3 3 25 5 8 97 142
2022/20231.134 129 104 11 127 60 117 7 55 464 12 34 14
2023/2024364 66 43 15 18 34 69 41 23 0 15 10 30
2024/20251.048 20 73 20 21 20 70 87 26 282 56 128 245
2025/20261.218 164 146 256 255 304 93 0 0 0 0 0 0
Totale 4.458